• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Neoadjuvant radiation therapy for esophageal cancer: is a higher dose better?食管癌的新辅助放射治疗：更高剂量会更好吗？
J Thorac Dis. 2019 Dec;11(12):5631-5634. doi: 10.21037/jtd.2019.11.77.
2
Prognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy.新辅助放化疗治疗食管癌患者肺部放疗剂量的预后意义。
Radiat Oncol. 2019 May 24;14(1):85. doi: 10.1186/s13014-019-1283-3.
3
What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer?新辅助化疗、放疗及辅助治疗在可切除食管癌中起什么作用？
Ann Cardiothorac Surg. 2017 Mar;6(2):167-174. doi: 10.21037/acs.2017.03.16.
4
Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.新辅助伊立替康、顺铂以及塞来昔布同步放疗用于局部晚期食管癌患者的治疗
BMC Cancer. 2016 Jul 13;16:468. doi: 10.1186/s12885-016-2485-9.
5
Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma.前瞻性、开放、多中心 I/II 期试验，评估多西他赛和顺铂新辅助放化疗治疗食管癌的安全性和疗效。
Jpn J Clin Oncol. 2015 Feb;45(2):169-75. doi: 10.1093/jjco/hyu181. Epub 2014 Nov 21.
6
Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.对于接受新辅助放化疗和经裂孔食管切除术治疗的食管癌患者，辐射剂量并不影响吻合口并发症。
Radiat Oncol. 2015 Mar 6;10:59. doi: 10.1186/s13014-015-0361-4.
7
Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis.新辅助放化疗后手术治疗食管癌患者的辐射剂量与病理反应：多机构分析。
Acta Oncol. 2019 Oct;58(10):1358-1365. doi: 10.1080/0284186X.2019.1646432. Epub 2019 Aug 21.
8
Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.术前采用紫杉醇、卡铂、延长输注5-氟尿嘧啶联合放疗治疗局部食管癌：米妮·珀尔癌症研究网络II期试验的初步结果
Cancer J Sci Am. 1999 Mar-Apr;5(2):84-91.
9
Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options.新辅助治疗还是 upfront 手术？T2N0 食管癌治疗选择的系统评价和荟萃分析。
Int J Surg. 2018 Jun;54(Pt A):176-181. doi: 10.1016/j.ijsu.2018.04.053. Epub 2018 May 3.
10
Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer.术前放化疗后食管癌的放射剂量与病理完全缓解的关系。
Anticancer Res. 2014 Dec;34(12):7255-61.

本文引用的文献

1
Induction Radiation Therapy for Esophageal Cancer: Does Dose Affect Outcomes?诱导放疗治疗食管癌：剂量是否影响疗效？
Ann Thorac Surg. 2019 Mar;107(3):903-911. doi: 10.1016/j.athoracsur.2018.09.064. Epub 2018 Nov 13.
2
Salvage esophagectomy for persistent or recurrent disease after definitive chemoradiation.对于确定性放化疗后持续或复发疾病行挽救性食管切除术。
Ann Cardiothorac Surg. 2017 Mar;6(2):144-151. doi: 10.21037/acs.2017.03.02.
3
Preoperative chemoradiotherapy for esophageal or junctional cancer.术前放化疗治疗食管或食管胃交界癌。
N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.
4
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.顺铂、氟尿嘧啶、放疗及手术三联疗法与单纯手术治疗食管癌的III期试验：癌症和白血病B组9781研究
J Clin Oncol. 2008 Mar 1;26(7):1086-92. doi: 10.1200/JCO.2007.12.9593.
5
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.单纯手术与放化疗后手术治疗可切除食管癌的对比：一项随机对照III期试验
Lancet Oncol. 2005 Sep;6(9):659-68. doi: 10.1016/S1470-2045(05)70288-6.
6
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.INT 0123（放射治疗肿瘤学组94-05）食管癌综合治疗的III期试验：高剂量与标准剂量放射治疗。
J Clin Oncol. 2002 Mar 1;20(5):1167-74. doi: 10.1200/JCO.2002.20.5.1167.
7
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.局部晚期食管癌患者术前放化疗与单纯手术的随机试验。
J Clin Oncol. 2001 Jan 15;19(2):305-13. doi: 10.1200/JCO.2001.19.2.305.
8
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus.肿瘤协作组0122试验（东部肿瘤协作组PE - 289，放射肿瘤学组90 - 12）最终报告：食管癌新辅助化疗联合同步化疗及高剂量放疗的II期试验。
Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):517-23. doi: 10.1016/s0360-3016(98)00463-5.
9
A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.食管腺癌多模式治疗与手术治疗的比较
N Engl J Med. 1996 Aug 15;335(7):462-7. doi: 10.1056/NEJM199608153350702.

Neoadjuvant radiation therapy for esophageal cancer: is a higher dose better?

作者信息

Haque Waqar, Butler E Brian, Teh Bin S

机构信息

Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA.

出版信息

J Thorac Dis. 2019 Dec;11(12):5631-5634. doi: 10.21037/jtd.2019.11.77.

DOI:10.21037/jtd.2019.11.77
PMID:32030286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6988049/
Abstract
摘要